Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.80
Bid: 63.20
Ask: 65.80
Change: 0.40 (0.61%)
Spread: 2.60 (4.114%)
Open: 65.80
High: 65.80
Low: 65.80
Prev. Close: 65.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Idox Compliance

12 Mar 2021 07:00

RNS Number : 0293S
IDOX PLC
12 March 2021
 

12 March 2021

 

Idox plc

('Idox' or the 'Group' or the 'Company')

Disposal of Idox Compliance

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, today announces that it has agreed the disposal of its Compliance Operations business, to Sponge Group Limited, a digital learning and technology company, for £9.0m cash on completion. The Compliance Operations business, part of Idox's Content Division is based in Germany and Belgium and employs 48 people.

The transaction will see Sponge acquire the entire share capital of Idox Germany GmbH and Idox Belgium BV together with a number of UK-based customer contracts. Idox Compliance is one of Europe's leading providers of compliance solutions, providing customers with e-learning platforms focused on supporting organisations to comply with compliance law and regulation.

The Compliance Operations reported revenues of £5.3m, an adjusted EBITDA contribution of £1.2m and PBT of £0.3m in Idox's financial year ended 31 October 2020. Gross assets as at 31 October 2020 were £5.4m. The disposal is anticipated to generate a profit on sale of £5.4m in the Group's current financial year.

 

The proceeds of the disposal will be utilised to reduce Idox's net debt (which stood at £16.1m as at 31 October 2020) and to continue to invest its organic and inorganic growth strategy.

Following the disposal, Idox's successful Grants Consultancy business now makes up the entirety of its Content Division.

David Meaden, CEO of Idox said:

"Our strategy, as stated in our recent FY20 results, is to build value as a public-sector focused software organisation. Whilst we are pleased with the progress of our Compliance business in the last two years, within our Four Pillars Framework, this transaction provides us with an opportunity to simplify operations within the Group and focus on our key markets, whilst at the same time providing the Compliance business with a more relevant owner in order to realise its own ambitions.

I look forward to seeing the continued success of the Idox Compliance team and products as it moves into its next phase with Sponge."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for making this notification is Ruth Paterson, Company Secretary.

 

-Ends-

Enquiries:

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive ChairmanDavid Meaden, Chief ExecutiveRob Grubb, Chief Financial OfficerPeel Hunt LLP (NOMAD and Broker) +44 (0) 20 7418 8900Edward KnightPaul GillamNick ProwtingMHP Communications  + 44 (0) 203 128 8100Reg Hoare / James Bavister / Amy O'Sullivan idox@mhpc.com 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFLLFFXLZBBX
Date   Source Headline
14th Nov 20227:00 amRNSHolding(s) in Company
7th Oct 20222:42 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSAcquisition
26th Sep 20227:00 amRNSExercise of Share Options & Total Voting Rights
1st Aug 20227:00 amRNSTotal Voting Rights
15th Jul 20227:00 amRNSIdox awarded new contract for Idox Cloud
28th Jun 20227:00 amRNSIssue of Equity
15th Jun 20227:00 amRNSHalf-year Report
19th May 20227:00 amRNSFY22 H1 trading update
19th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSGrant of Options
28th Mar 20227:13 amRNSExercise of Share Options & Total Voting Rights
23rd Mar 20229:51 amRNSExercise of Share Options & Total Voting Rights
16th Mar 202211:22 amRNSResult of AGM & Board Change
16th Mar 20227:00 amRNSAGM Trading Update
21st Feb 20227:01 amRNSPosting of Annual Report and Notice of AGM
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.